Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

Article  PubMed  Google Scholar 

Conyers R, Young S, Thomas DM. Liposarcoma: molecular genetics and therapeutics. Sarcoma. 2011;2011: 483154.

Article  PubMed  Google Scholar 

Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381–91.

Article  PubMed  PubMed Central  Google Scholar 

Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238:358–70 (discussion 370-351).

Article  PubMed  PubMed Central  Google Scholar 

Raut CP, Callegaro D, Miceli R, Barretta F, Rutkowski P, Blay JY, Lahat G, Strauss DC, Gonzalez R, Ahuja N, et al. Predicting survival in patients undergoing resection for locally recurrent retroperitoneal sarcoma: a study and novel nomogram from TARPSWG. Clin Cancer Res. 2019;25:2664–71.

Article  PubMed  Google Scholar 

MacNeill AJ, Miceli R, Strauss DC, Bonvalot S, Hohenberger P, Van Coevorden F, Rutkowski P, Callegaro D, Hayes AJ, Honoré C, et al. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: a report from the Trans-Atlantic RPS Working Group. Cancer. 2017;123:1971–8.

Article  CAS  PubMed  Google Scholar 

Gronchi A, Miceli R, Allard MA, Callegaro D, Le Péchoux C, Fiore M, Honoré C, Sanfilippo R, Coppola S, Stacchiotti S, et al. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection. Ann Surg Oncol. 2015;22:1447–54.

Article  PubMed  Google Scholar 

Bill KLJ, Seligson ND, Hays JL, Awasthi A, Demoret B, Stets CW, Duggan MC, Bupathi M, Brock GN, Millis SZ, et al. Degree of MDM2 amplification affects clinical outcomes in dedifferentiated liposarcoma. Oncologist. 2019;24:989–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lou Y, Ma Y, Li H, Song Y, Zhang X, Lin H, Zhang X, Ling J. High expression of fibroblast growth factor-21 in liposarcoma patients indicated better prognosis and less recurrence. Biochem Biophys Res Commun. 2018;503:1130–3.

Article  CAS  PubMed  Google Scholar 

Loria R, Laquintana V, Bon G, Trisciuoglio D, Covello R, Amoreo CA, Ferraresi V, Zoccali C, D’Incalci M, Biagini R, Falcioni R. 1689PHMGA1 is a new biomarker of liposarcoma progression. Ann Oncol. 2017;28:v591.

Article  Google Scholar 

Tajima T, Kito F, Yoshida A, Kawai A, Kondo T. Calreticulin as a novel potential metastasis-associated protein in myxoid liposarcoma, as revealed by two-dimensional difference gel electrophoresis. Proteomes. 2019;7:13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Renner M, Wolf T, Meyer H, Hartmann W, Penzel R, Ulrich A, Lehner B, Hovestadt V, Czwan E, Egerer G, et al. Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas. Genome Biol. 2013;14: r137.

Article  PubMed  PubMed Central  Google Scholar 

Aoyama T, Takasawa A, Takasawa K, Ono Y, Emori M, Murata M, Hayasaka T, Fujitani N, Osanai M, Yamashita T, et al. Identification of coiled-coil domain-containing protein 180 and leucine-rich repeat-containing protein 4 as potential immunohistochemical markers for liposarcoma based on proteomic analysis using formalin-fixed, paraffin-embedded tissue. Am J Pathol. 2019;189:1015–28.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Tong H, He J, Shao Y, Guo X, Zhuang R, Yang J, Liu J, Ding Y, Liu W, et al. Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3. Cell Death Dis. 2019;10:430.

Article  PubMed  PubMed Central  Google Scholar 

Mazzu YZ, Hu Y, Soni RK, Mojica KM, Qin LX, Agius P, Waxman ZM, Mihailovic A, Socci ND, Hendrickson RC, et al. miR-193b-regulated signaling networks serve as tumor suppressors in liposarcoma and promote adipogenesis in adipose-derived stem cells. Cancer Res. 2017;77:5728–40.

Article  CAS  PubMed  Google Scholar 

Cui L, Tian X, Yan L, Guan X, Dong B, Zhao M, Lv A, Liu D, Wu J, Hao C. Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: bioinformatics analysis and clinicopathological evidence. Int J Med Sci. 2022;19:1977–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu C, Yan L, Guan X, Wang Z, Wu J, Lv A, Liu D, Liu F, Dong B, Zhao M, et al. Tsp2 facilitates tumor-associated fibroblasts formation and promotes tumor progression in retroperitoneal liposarcoma. Int J Biol Sci. 2022;18:5038–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nezu Y, Hagiwara K, Yamamoto Y, Fujiwara T, Matsuo K, Yoshida A, Kawai A, Saito T, Ochiya T. miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma. Oncogene. 2016;35:6177–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Costa-Pinheiro P, Montezuma D, Henrique R, Jerónimo C. Diagnostic and prognostic epigenetic biomarkers in cancer. Epigenomics. 2015;7:1003–15.

Article  CAS  PubMed  Google Scholar 

Network CGAR. Comprehensive and integrated genomic characterization of adult soft tissue sarcomas. Cell. 2017;171:950-965.e928.

Article  Google Scholar 

Li T, Wang W, Gong S, Sun H, Zhang H, Yang AG, Chen YH, Li X. Genome-wide analysis reveals TNFAIP8L2 as an immune checkpoint regulator of inflammation and metabolism. Mol Immunol. 2018;99:154–62.

Article  PubMed  PubMed Central  Google Scholar 

Liu B, Huang Y, Sun Y, Zhang J, Yao Y, Shen Z, Xiang D, He A. Prognostic value of inflammation-based scores in patients with osteosarcoma. Sci Rep. 2016;6:39862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu G, Ke LC, Sun SR. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: a meta-analysis. Medicine (Baltimore). 2018;97: e12176.

Article  PubMed  Google Scholar 

Lee HJ, Ahn BJ, Shin MW, Choi JH, Kim KW. Ninjurin1: a potential adhesion molecule and its role in inflammation and tissue remodeling. Mol Cells. 2010;29:223–7.

Article  CAS  PubMed  Google Scholar 

Verma M. The role of epigenomics in the study of cancer biomarkers and in the development of diagnostic tools. Adv Exp Med Biol. 2015;867:59–80.

Article  CAS  PubMed  Google Scholar 

Li YJ, Yang X, Zhang WB, Yi C, Wang F, Li P. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma. Cancer Manag Res. 2017;9:443–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song F, Yi Y, Li C, Hu Y, Wang J, Smith DE, Jiang H. Regulation and biological role of the peptide/histidine transporter SLC15A3 in Toll-like receptor-mediated inflammatory responses in macrophage. Cell Death Dis. 2018;9:770.

Article  PubMed  PubMed Central  Google Scholar 

Ziegler-Heitbrock L. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol. 2007;81:584–92.

Article  CAS  PubMed  Google Scholar